ALK and non-small cell lung carcinoma: The echinoderm microtubule-associated protein-like 4 gene and the anaplastic lymphoma kinase gene (EML4-ALK) fusion oncogene was identified as a novel effective target in NSCLC in 2007 which has been detected in 5% NSCLC patients [114–116].